Company: SGBAF
Filing Date: 2025-01-17
Form Type: DRS/A
Source: 0000950123-25-000378
Chunk: 104

Company: SES S.A.
Filing Date: 2025-01-17
Form: DRS/A
Chunk 104
---
 and performance of the Share Purchase Agreement and the consummation of the Transactions; |

| • |     | the absence of defaults, breaches, violations, (including termination, cancellation or acceleration rights) or                                                                                                                         
 consents required under contracts, or creation of certain liens on assets or properties, in each case as a result of the execution, delivery and performance of the Share Purchase Agreement and the consummation of the Transactions; |

| • |     | notices, authorizations, approvals, orders, permits, consents and filings required by governmental authorities to 
 enter into the Share Purchase Agreement, perform obligations thereunder and consummate the Transactions;          |

| • |     | the absence of suits, claims, actions, proceedings or litigation pending or, to the knowledge of SES, threatened                                                    
 against SES or any of its subsidiaries or its respective assets or properties and the absence of certain orders against SES or its respective assets or properties; |

| • |     | completion of financing, validity of SES’s bridge facility agreement dated as of the date of the Share                                                
 Purchase Agreement (the “Bridge Facility Agreement”) and sufficiency of funds to make required payments pursuant to the Share Purchase Agreement; and |

| • |     | brokers’, finders’ and other fees or commissions. |

Some of the representations and warranties made by Intelsat are qualified as to materiality with respect to Intelsat or by exceptions related to a material adverse effect with respect to Intelsat. Under the Share Purchase Agreement, the term “material adverse effect” with respect to Intelsat means any event, change, occurrence or effect that has, or would reasonably be expected to have, a material adverse effect on the business, financial condition or results of operations of Intelsat and its subsidiaries (excluding any Excluded Liabilities), taken as a 68

Confidential Treatment Requested by SES Pursuant to 17 C.F.R. Section 200.83 whole; provided, however, that in no event, change, circumstance, occurrence or effect to the extent directly or indirectly resulting from, arising out of, attributable to, or relating to any of the following will be deemed to be or constitute a material adverse effect with respect to Intelsat or will be taken into account when determining whether a material adverse effect with respect to Intelsat has occurred or would occur:

| • |     | any changes in general economic or business conditions or in the financial, debt, banking, capital, credit or       
 securities markets, or in interest or